About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 457079, 10 pages
http://dx.doi.org/10.1155/2011/457079
Review Article

Kainic Acid-Induced Neurodegenerative Model: Potentials and Limitations

1Department of Neurosurgery, The First Hospital of Jilin University, Changchun 130021, China
2Department of Neurobiology, Care Science and Society, Karolinska Institute, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden
3Department of Neurology, the First Hospital of Jilin University, Changchun 130021, China

Received 14 September 2010; Accepted 25 October 2010

Academic Editor: Monica Fedele

Copyright © 2011 Xiang-Yu Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Vincent and C. Mulle, “Kainate receptors in epilepsy and excitotoxicity,” Neuroscience, vol. 158, no. 1, pp. 309–323, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. Q. Wang, S. Yu, A. Simonyi, G. Y. Sun, and A. Y. Sun, “Kainic acid-mediated excitotoxicity as a model for neurodegeneration,” Molecular Neurobiology, vol. 31, no. 1–3, pp. 3–16, 2005. View at Scopus
  3. J. N. C. Kew and J. A. Kemp, “Ionotropic and metabotropic glutamate receptor structure and pharmacology,” Psychopharmacology, vol. 179, no. 1, pp. 4–29, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. G. L. Collingridge, R. W. Olsen, J. Peters, and M. Spedding, “A nomenclature for ligand-gated ion channels,” Neuropharmacology, vol. 56, no. 1, pp. 2–5, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. Y. Ben-Ari, “Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy,” Neuroscience, vol. 14, no. 2, pp. 375–403, 1985. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Mulle, A. Sailer, I. Pérez-Otaño et al., “Altered synaptic physiology and reduced susceptibility to kainate- induced secures in GluR6-deficient mice,” Nature, vol. 392, no. 6676, pp. 601–605, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. Y.-C. Chuang, A. Y. W. Chang, J.-W. Lin, S.-P. Hsu, and S. H. H. Chan, “Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat,” Epilepsia, vol. 45, no. 10, pp. 1202–1209, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. S. Ratté and J. C. Lacaille, “Selective degeneration and synaptic reorganization of hippocampal interneurons in a chronic model of temporal lobe epilepsy,” Advances in Neurology, vol. 97, pp. 69–76, 2006. View at Scopus
  9. I. Gröticke, K. Hoffmann, and W. Löscher, “Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate,” Experimental Neurology, vol. 213, no. 1, pp. 71–83, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. O. L. Gobbo and S. M. O'Mara, “Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration,” Neuroscience, vol. 125, no. 2, pp. 317–327, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. O. L. Gobbo and S. M. O'Mara, “Exercise, but not environmental enrichment, improves learning after kainic acid-induced hippocampal neurodegeneration in association with an increase in brain-derived neurotrophic factor,” Behavioural Brain Research, vol. 159, no. 1, pp. 21–26, 2005. View at Publisher · View at Google Scholar · View at PubMed
  12. L. E. Jarrard, “Use of excitotoxins to lesion the hippocampus: update,” Hippocampus, vol. 12, no. 3, pp. 405–414, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. E. B. Bloss and R. G. Hunter, “Hippocampal kainate receptors,” Vitamins and Hormones, vol. 82, pp. 167–184, 2010. View at Publisher · View at Google Scholar
  14. S. G. Carriedo, S. L. Sensi, H. Z. Yin, and J. H. Weiss, “AMPA exposures induce mitochondrial Ca2+ overload and ROS generation in spinal motor neurons in vitro,” Journal of Neuroscience, vol. 20, no. 1, pp. 240–250, 2000. View at Scopus
  15. S. E. Lauri, Z. A. Bortolotto, D. Bleakman et al., “A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP,” Neuron, vol. 32, no. 4, pp. 697–709, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Contractor, A. W. Sailer, M. Darstein et al., “Loss of kainate receptor-mediated heterosynaptic facilitation of mossy-fiber synapses in KA2-/- mice,” Journal of Neuroscience, vol. 23, no. 2, pp. 422–429, 2003. View at Scopus
  17. A. Rodríguez-Moreno and T. S. Sihra, “Presynaptic kainate receptor facilitation of glutamate release involves protein kinase A in the rat hippocampus,” Journal of Physiology, vol. 557, no. 3, pp. 733–745, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. H. N. Lee, G. S. Jeon, D. W. Kim, I.-H. Cho, and S. S. Cho, “Expression of adenomatous polyposis coli protein in reactive astrocytes in hippocampus of kainic acid-induced rat,” Neurochemical Research, vol. 35, no. 1, pp. 114–121, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. J. P. McLin and O. Steward, “Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains,” European Journal of Neuroscience, vol. 24, no. 8, pp. 2191–2202, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Kasugai, K. Akaike, S.-I. Imamura et al., “Differences in two mice strains on kainic acid-induced amygdalar seizures,” Biochemical and Biophysical Research Communications, vol. 357, no. 4, pp. 1078–1083, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. G. L. Pereno and C. A. Beltramino, “Differential role of gonadal hormones on kainic acid-induced neurodegeneration in medial amygdaloid nucleus of female and male rats,” Neuroscience, vol. 163, no. 3, pp. 952–963, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A.-L. Sokka, N. Putkonen, G. Mudo et al., “Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain,” Journal of Neuroscience, vol. 27, no. 4, pp. 901–908, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. L. De Lemos, F. Junyent, E. Verdaguer et al., “Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment,” Journal of Neurochemistry, vol. 114, no. 5, pp. 1315–1322, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. I.-H. Cho, J. Hong, E. C. Suh et al., “Role of microglial IKKβ in kainic acid-induced hippocampal neuronal cell death,” Brain, vol. 131, no. 11, pp. 3019–3033, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. Z. Chen, R.-S. Duan, H. C. Quezada et al., “Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice,” Journal of Neurobiology, vol. 62, no. 2, pp. 207–218, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. T. Ravizza, M. Rizzi, C. Perego et al., “Inflammatory response and glia activation in developing rat hippocampus after status epilepticus,” Epilepsia, vol. 46, supplement 5, pp. 113–117, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. C. L. Mack, C. L. Vanderlugt-Castaneda, K. L. Neville, and S. D. Miller, “Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis,” Journal of Neuroimmunology, vol. 144, no. 1-2, pp. 68–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Kato and W. Walz, “The initiation of the microglial response,” Brain Pathology, vol. 10, no. 1, pp. 137–143, 2000. View at Scopus
  29. I. Napoli and H. Neumann, “Protective effects of microglia in multiple sclerosis,” Experimental Neurology, vol. 225, no. 1, pp. 24–28, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. L. Marinova-Mutafchieva, M. Sadeghian, L. Broom, J. B. Davis, A. D. Medhurst, and D. T. Dexter, “Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease,” Journal of Neurochemistry, vol. 110, no. 3, pp. 966–975, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. Venneti, C. A. Wiley, and J. Kofler, “Imaging microglial activation during neuroinflammation and Alzheimer's disease,” Journal of Neuroimmune Pharmacology, vol. 4, no. 2, pp. 227–243, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. M. Penkowa, A. Molinero, J. Carrasco, and J. Hidalgo, “Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures,” Neuroscience, vol. 102, no. 4, pp. 805–818, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-S. Byun, J.-W. Lee, S. Y. Kim et al., “Neuroprotective effects of stanniocalcin 2 following kainic acid-induced hippocampal degeneration in ICR mice,” Peptides, vol. 31, no. 11, pp. 2094–2099, 2010. View at Publisher · View at Google Scholar · View at PubMed
  34. C. Giaume, F. Kirchhoff, C. Matute, A. Reichenbach, and A. Verkhratsky, “Glia: the fulcrum of brain diseases,” Cell Death and Differentiation, vol. 14, no. 7, pp. 1324–1335, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. S. S. Gill, Y. Hou, T. Ghane, and O. M. Pulido, “Regional susceptibility to domoic acid in primary astrocyte cells cultured from the brain stem and hippocampus,” Marine Drugs, vol. 6, no. 1, pp. 25–38, 2008. View at Scopus
  36. S. Vesce, D. Rossi, L. Brambilla, and A. Volterra, “Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation,” International Review of Neurobiology, vol. 82, pp. 57–71, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. A. Braun, J. Dang, S. Johann, C. Beyer, and M. Kipp, “Selective regulation of growth factor expression in cultured cortical astrocytes by neuro-pathological toxins,” Neurochemistry International, vol. 55, no. 7, pp. 610–618, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. G. D. Dakubo, S. T. Beug, C. J. Mazerolle, S. Thurig, Y. Wang, and V. A. Wallace, “Control of glial precursor cell development in the mouse optic nerve by sonic hedgehog from retinal ganglion cells,” Brain Research, vol. 1228, no. C, pp. 27–42, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. J. K. Sandhu, M. Gardaneh, R. Iwasiow et al., “Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity,” Neurobiology of Disease, vol. 33, no. 3, pp. 405–414, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. E. Brand-Schieber and P. Werner, “AMPA/kainate receptors in mouse spinal cord cell-specific display of receptor subunits by oligodendrocytes and astrocytes and at the nodes of Ranvier,” GLIA, vol. 42, no. 1, pp. 12–24, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. M. T. Heneka, J. J. Rodríguez, and A. Verkhratsky, “Neuroglia in neurodegeneration,” Brain Research Reviews, vol. 63, no. 1-2, pp. 189–211, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. C. Bendotti, F. Guglielmetti, M. Tortarolo, R. Samanin, and W. D. Hirst, “Differential expression of S100β and glial fibrillary acidic protein in the hippocampus after kainic acid-induced lesions and mossy fiber sprouting in adult rat,” Experimental Neurology, vol. 161, no. 1, pp. 317–329, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. M. Ding, K. G. Haglid, and A. Hamberger, “Quantitative immunochemistry on neuronal loss, reactive gliosis and BBB damage in cortex/striatum and hippocampus/amygdala after systemic kainic acid administration,” Neurochemistry International, vol. 36, no. 4-5, pp. 313–318, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Saito, S.-I. Hino, T. Murakami, S. Kondo, and K. Imaizumi, “A novel ER stress transducer, OASIS, expressed in astrocytes,” Antioxidants and Redox Signaling, vol. 9, no. 5, pp. 563–571, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. K. Chihara, A. Saito, T. Murakami et al., “Increased vulnerability of hippocampal pyramidal neurons to the toxicity of kainic acid in OASIS-deficient mice,” Journal of Neurochemistry, vol. 110, no. 3, pp. 956–965, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. M. R. Vargas, D. A. Johnson, D. W. Sirkis, A. Messing, and J. A. Johnson, “Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis,” Journal of Neuroscience, vol. 28, no. 50, pp. 13574–13581, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. M. R. Vargas and J. A. Johnson, “The Nrf2-ARE cytoprotective pathway in astrocytes,” Expert Reviews in Molecular Medicine, vol. 11, article no. e17, 2009. View at Publisher · View at Google Scholar · View at PubMed
  48. S. L. Campbell, S. S. Mathew, and J. J. Hablitz, “Pre- and postsynaptic effects of kainate on layer II/III pyramidal cells in rat neocortex,” Neuropharmacology, vol. 53, no. 1, pp. 37–47, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. D.-H. Youn and M. Randić, “Modulation of excitatory synaptic transmission in the spinal substantia gelatinosa of mice deficient in the kainate receptor GluR5 and/or GluR6 subunit,” Journal of Physiology, vol. 555, no. 3, pp. 683–698, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. J. R. Brorson, P. A. Manzolillo, and R. J. Miller, “Ca2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells,” Journal of Neuroscience, vol. 14, no. 1, pp. 187–197, 1994. View at Scopus
  51. M. V. Frantseva, J. L. Perez Velazquez, G. Tsoraklidis et al., “Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy,” Neuroscience, vol. 97, no. 3, pp. 431–435, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Swamy, K. N.S. Sirajudeen, and G. Chandran, “Nitric oxide (NO), citrullineNO cycle enzymes, glutamine synthetase, and oxidative status in kainic acid-mediated excitotoxicity in rat brain,” Drug and Chemical Toxicology, vol. 32, no. 4, pp. 326–331, 2009. View at Publisher · View at Google Scholar · View at PubMed
  53. T. Nakaki, A. Mishima, E. Suzuki, F. Shintani, and T. Fujii, “Glufosinate ammonium stimulates nitric oxide production through N-methyl D-aspartate receptors in rat cerebellum,” Neuroscience Letters, vol. 290, no. 3, pp. 209–212, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Prast and A. Philippu, “Nitric oxide as modulator of neuronal function,” Progress in Neurobiology, vol. 64, no. 1, pp. 51–68, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Ueda, H. Yokoyama, A. Nakajima, J. Tokumaru, T. Doi, and Y. Mitsuyama, “Glutamate excess and free radical formation during and following kainic acid-induced status epilepticus,” Experimental Brain Research, vol. 147, no. 2, pp. 219–226, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. E. J. Kim, J. E. Lee, K. J. Kwon, S. H. Lee, C.-H. Moon, and E. J. Baik, “Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E2 production and neurodegeneration in cortical and hippocampal cell cultures,” Brain Research, vol. 908, no. 1, pp. 1–9, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Takemiya, K. Matsumura, and K. Yamagata, “Roles of prostaglandin synthesis in excitotoxic brain diseases,” Neurochemistry International, vol. 51, no. 2–4, pp. 112–120, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. T. Takemiya, M. Maehara, K. Matsumura, S. Yasuda, H. Sugiura, and K. Yamagata, “Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region,” Neuroscience Research, vol. 56, no. 1, pp. 103–110, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. K. Kawaguchi, R. W. Hickey, M. E. Rose, L. Zhu, J. Chen, and S. H. Graham, “Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus,” Brain Research, vol. 1050, no. 1-2, pp. 130–137, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. M. Patel, L.-P. Liang, H. Hou et al., “Seizure-induced formation of isofurans: novel products of lipid peroxidation whose formation is positively modulated by oxygen tension,” Journal of Neurochemistry, vol. 104, no. 1, pp. 264–270, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. L. E. Rojo, J. A. Fernández, A. A. Maccioni, J. M. Jimenez, and R. B. Maccioni, “Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease,” Archives of Medical Research, vol. 39, no. 1, pp. 1–16, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. J. L. Bennett and O. Stüve, “Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications,” Clinical Neuropharmacology, vol. 32, no. 3, pp. 121–132, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. C. A. Colton and D. M. Wilcock, “Assessing activation states in microglia,” CNS and Neurological Disorders, vol. 9, no. 2, pp. 174–191, 2010.
  64. M. Kerschensteiner, E. Meinl, and R. Hohlfeld, “Neuro-immune crosstalk in CNS diseases,” Neuroscience, vol. 158, no. 3, pp. 1122–1132, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. Z. Chen, R.-S. Duan, Q. H. Concha et al., “IL-12p35 deficiency alleviates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice,” Neurobiology of Disease, vol. 17, no. 2, pp. 171–178, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. D. J. Stuehr, H. J. Cho, N. S. Kwon, M. F. Weise, and C. F. Nathan, “Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 17, pp. 7773–7777, 1991. View at Scopus
  67. H. Wiesinger, “Arginine metabolism and the synthesis of nitric oxide in the nervous system,” Progress in Neurobiology, vol. 64, no. 4, pp. 365–391, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. U.-K. Hanisch, “Microglia as a source and target of cytokines,” GLIA, vol. 40, no. 2, pp. 140–155, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. S. Amor, F. Puentes, D. Baker, and P. Van Der Valk, “Inflammation in neurodegenerative diseases,” Immunology, vol. 129, no. 2, pp. 154–169, 2010. View at Publisher · View at Google Scholar · View at PubMed
  70. J.-S. Byun, S.-H. Lee, S.-H. Jeon et al., “Kainic acid-induced neuronal death is attenuated by aminoguanidine but aggravated by L-NAME in mouse hippocampus,” Korean Journal of Physiology and Pharmacology, vol. 13, no. 4, pp. 265–271, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. M. Yamamoto, K. Yoshizaki, T. Kishimoto, and H. Ito, “IL-6 is required for the development of Th1 cell-mediated murine colitis,” Journal of Immunology, vol. 164, no. 9, pp. 4878–4882, 2000. View at Scopus
  72. S. Diehl and M. Rincón, “The two faces of IL-6 on Th1/Th2 differentiation,” Molecular Immunology, vol. 39, no. 9, pp. 531–536, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. K. A. Lehtimäki, J. Peltola, E. Koskikallio, T. Keränen, and J. Honkaniemi, “Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures,” Molecular Brain Research, vol. 110, no. 2, pp. 253–260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. C. All, O. Nicole, F. Docagne et al., “Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitoxicity in the brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 20, no. 6, pp. 956–966, 2000. View at Scopus
  75. G. De Sarro, E. Russo, G. Ferreri et al., “Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice,” Pharmacology Biochemistry and Behavior, vol. 77, no. 4, pp. 761–766, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. M. Penkowa, A. Molinero, J. Carrasco, and J. Hidalgo, “Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures,” Neuroscience, vol. 102, no. 4, pp. 805–818, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Stoll, S. Jander, and M. Schroeter, “Cytokines in CNS disorders: neurotoxicity versus neuroprotection,” Journal of Neural Transmission, no. 59, supplement, pp. 81–89, 2000. View at Scopus
  78. X.-M. Zhang, R.-S. Duan, Z. Chen et al., “IL-18 deficiency aggravates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice due to an overcompensation by IL-12,” Experimental Neurology, vol. 205, no. 1, pp. 64–73, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. R. Kiefer, W. J. Streit, K. V. Toyka, G. W. Kreutzberg, and H.-P. Hartung, “Transforming growth factor-β1: a lesion-associated cytokine of the nervous system,” International Journal of Developmental Neuroscience, vol. 13, no. 3-4, pp. 331–339, 1995. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Boche, C. Cunningham, J. Gauldie, and V. H. Perry, “Transforming growth factor-β1-mediated neuroprotection against excitotoxic injury in vivo,” Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 10, pp. 1174–1182, 2003. View at Scopus
  81. T. E. Morgan, N. R. Nichols, G. M. Pasinetti, and C. E. Finch, “TGF-β1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration,” Experimental Neurology, vol. 120, no. 2, pp. 291–301, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. H.-C. Kim, G. Bing, S.-J. Kim et al., “Kainate treatment alters TGF-β3 gene expression in the rat hippocampus,” Molecular Brain Research, vol. 108, no. 1-2, pp. 60–70, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. M.-O. Lu, X.-M. Zhang, E. Mix et al., “TNF-α receptor 1 deficiency enhances kainic acid-induced hippocampal injury in mice,” Journal of Neuroscience Research, vol. 86, no. 7, pp. 1608–1614, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. C. Thompson, D. Gary, M. Mattson, A. Mackenzie, and G. S. Robertson, “Kainic acid-induced naip expression in the hippocampus is blocked in mice lacking TNF receptors,” Molecular Brain Research, vol. 123, no. 1-2, pp. 126–131, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. S. Balosso, T. Ravizza, C. Perego et al., “Tumor necrosis factor-α inhibits seizures in mice via p75 receptors,” Annals of Neurology, vol. 57, no. 6, pp. 804–812, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. W. Zhu, H. Zheng, X. Shao, W. Wang, Q. Yao, and Z. Li, “Excitotoxicity of TNFα derived from KA activated microglia on hippocampal neurons in vitro and in vivo,” Journal of Neurochemistry, vol. 114, no. 2, pp. 386–396, 2010. View at Publisher · View at Google Scholar · View at PubMed
  87. T. Kanno, T. Nagata, S. Yamamoto, H. Okamura, and T. Nishizaki, “Interleukin-18 stimulates synaptically released glutamate and enhances postsynaptic AMPA receptor responses in the CA1 region of mouse hippocampal slices,” Brain Research, vol. 1012, no. 1-2, pp. 190–193, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. S. Sugama, S. A. Wirz, A. M. Barr, B. Conti, T. Bartfai, and T. Shibasaki, “Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine treatment,” Neuroscience, vol. 128, no. 2, pp. 451–458, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. G. S. Jeon, S. K. Park, S. W. Park, D. W. Kim, C. K. Chung, and S. S. Cho, “Glial expression of interleukin-18 and its receptor after excitotoxic damage in the mouse hippocampus,” Neurochemical Research, vol. 33, no. 1, pp. 179–184, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. D. Wang, S. Zhang, L. Li, X. Liu, K. Mei, and X. Wang, “Structural insights into the assembly and activation of IL-1β 2 with its receptors,” Nature Immunology, vol. 11, no. 10, pp. 905–911, 2010. View at Publisher · View at Google Scholar · View at PubMed
  91. M. Oprica, C. Eriksson, and M. Schultzberg, “Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system,” Journal of Cellular and Molecular Medicine, vol. 7, no. 2, pp. 127–140, 2003. View at Scopus
  92. B. Liu and J.-S. Hong, “Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention,” Journal of Pharmacology and Experimental Therapeutics, vol. 304, no. 1, pp. 1–7, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. H. Zheng, W. Zhu, H. Zhao, X. Wang, W. Wang, and Z. Li, “Kainic acid-activated microglia mediate increased excitability of rat hippocampal neurons in vitro and in vivo: crucial role of interleukin-1beta,” NeuroImmunoModulation, vol. 17, no. 1, pp. 31–38, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. Z. Chen, H.-G. Ljunggren, N. Bogdanovic, I. Nennesmo, B. Winblad, and J. Zhu, “Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice,” Brain Research, vol. 931, no. 2, pp. 135–145, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. L. Illum, “Transport of drugs from the nasal cavity to the central nervous system,” European Journal of Pharmaceutical Sciences, vol. 11, no. 1, pp. 1–18, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. A. A. Montague and C. A. Greer, “Differential distribution of ionotropic glutamate receptor subunits in the rat olfactory bulb,” Journal of Comparative Neurology, vol. 405, no. 2, pp. 233–246, 1999. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Mathison, R. Nagilla, and U. B. Kompella, “Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?” Journal of Drug Targeting, vol. 5, no. 6, pp. 415–441, 1998. View at Scopus
  98. T. Sakane, M. Akizuki, Y. Taki, S. Yamashita, H. Sezaki, and T. Nadai, “Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs,” Journal of Pharmacy and Pharmacology, vol. 47, no. 5, pp. 379–381, 1995. View at Scopus
  99. M. B. Genter, E. L. Kendig, and M. D. Knutson, “Uptake of materials from the nasal cavity into the blood and brain: are we finally beginning to understand these processes at the molecular level,” Annals of the New York Academy of Sciences, vol. 1170, no. 1, pp. 623–628, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. K. A. Johnson, P. J. Conn, and C. M. Niswender, “Glutamate receptors as therapeutic targets for Parkinson's disease,” CNS and Neurological Disorders, vol. 8, no. 6, pp. 475–491, 2009. View at Publisher · View at Google Scholar
  101. H. Ilieva, M. Polymenidou, and D. W. Cleveland, “Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond,” Journal of Cell Biology, vol. 187, no. 6, pp. 761–772, 2009. View at Publisher · View at Google Scholar · View at PubMed
  102. D. H. Kim, B. H. Yoon, W. Y. Jung et al., “Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice,” Neuropharmacology, vol. 59, no. 1-2, pp. 20–30, 2010. View at Publisher · View at Google Scholar · View at PubMed
  103. R. Miyamoto, S. Shimakawa, S. Suzuki, T. Ogihara, and H. Tamai, “Edaravone prevents kainic acid-induced neuronal death,” Brain Research, vol. 1209, no. 1, pp. 85–91, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  104. S.-Y. Chung and S.-H. Han, “Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition,” Journal of Pineal Research, vol. 34, no. 2, pp. 95–102, 2003. View at Publisher · View at Google Scholar
  105. X.-L. Zhu, L.-Z. Xiong, Q. Wang et al., “Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats,” Neuroscience Letters, vol. 449, no. 1, pp. 24–27, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. S.-Y. Li, Y.-H. Jia, W.-G. Sun et al., “Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus,” Free Radical Biology and Medicine, vol. 48, no. 4, pp. 597–608, 2010. View at Publisher · View at Google Scholar · View at PubMed
  107. G. T. Swanson, “Targeting AMPA and kainate receptors in neurological disease: therapies on the horizon?” Neuropsychopharmacology, vol. 34, no. 1, pp. 249–250, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. X.-M. Liu, D.-S. Pei, Q.-H. Guan et al., “Neuroprotection of Tat-GluR6-9c against neuronal death induced by kainate in rat hippocampus via nuclear and non-nuclear pathways,” Journal of Biological Chemistry, vol. 281, no. 25, pp. 17432–17445, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. D.-S. Pei, X.-T. Wang, Y. Liu et al., “Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence,” Brain, vol. 129, no. 2, pp. 465–479, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. H. Akashiba, N. Matsuki, and N. Nishiyama, “Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons,” Journal of Neurochemistry, vol. 99, no. 3, pp. 733–744, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  111. H. Akashiba, N. Matsuki, and N. Nishiyama, “p27 small interfering RNA induces cell death through elevating cell cycle activity in cultured cortical neurons: a proof-of-concept study,” Cellular and Molecular Life Sciences, vol. 63, no. 19-20, pp. 2397–2404, 2006. View at Publisher · View at Google Scholar · View at PubMed
  112. C. Ueyama, H. Akashiba, K. Nakayama, K. I. Nakayama, N. Nishiyama, and N. Matsuki, “Ablation of p27 enhance kainate-induced seizure and hippocampal degeneration,” NeuroReport, vol. 18, no. 17, pp. 1781–1785, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  113. I. M. Araújo, J. M. Gil, B. P. Carreira et al., “Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus,” Journal of Neurochemistry, vol. 105, no. 3, pp. 666–676, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. E. Verdaguer, E. G. Jordà, A. M. Canudas et al., “p21WAF1/Cip1 is not involved in kainic acid-induced apoptosis in murine cerebellar granule cells,” Brain Research, vol. 1030, no. 2, pp. 297–302, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  115. E. Verdaguer, E. García-Jordà, A. Jiménez et al., “Kainic acid-induced neuronal cell death in cerebellar granule cells is not prevented by caspase inhibitors,” British Journal of Pharmacology, vol. 135, no. 5, pp. 1297–1307, 2002. View at Scopus
  116. S. Jinap and P. Hajeb, “Glutamate. Its applications in food and contribution to health,” Appetite, vol. 55, no. 1, pp. 1–10, 2010. View at Publisher · View at Google Scholar · View at PubMed
  117. J. Yang, B. Houk, J. Shah et al., “Genetic background regulates semaphorin gene expression and epileptogenesis in mouse brain after kainic acid status epilepticus,” Neuroscience, vol. 131, no. 4, pp. 853–869, 2005. View at Publisher · View at Google Scholar · View at PubMed
  118. M. M. Aarts and M. Tymianski, “Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors,” Biochemical Pharmacology, vol. 66, no. 6, pp. 877–886, 2003. View at Publisher · View at Google Scholar · View at Scopus
  119. V. Thukral, D. Chikaraishi, D. D. Hunter, and J. K. T. Wang, “Expression of non-N-methyl-D-aspartate glutamate receptor subunits in the olfactory epithelium,” Neuroscience, vol. 79, no. 2, pp. 411–424, 1997. View at Publisher · View at Google Scholar · View at Scopus
  120. P. E. Schauwecker, “Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain,” Experimental Neurology, vol. 224, no. 1, pp. 207–218, 2010. View at Publisher · View at Google Scholar · View at PubMed